Life Science Tools Market (By Technology: Genomics, Cell Biology, Proteomics, Lab Supplies & Technologies, and Others ; By Product: Consumables, Instruments, Services; By End-use: Academic and Research Institutions, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, CROs, Government and Regulatory Agencies) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2024 - 2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Technology Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Life Science Tools Market, by Product Type, 2024-2033
7.1.1. NGS
7.1.1.1. Market Revenue and Forecast (2021-2033)
7.1.2. Sanger Sequencing
7.1.2.1. Market Revenue and Forecast (2021-2033)
7.1.3. Nucleic Acid Preparation
7.1.3.1. Market Revenue and Forecast (2021-2033)
7.1.4. Nucleic Acid Microarray
7.1.4.1. Market Revenue and Forecast (2021-2033)
7.1.5. PCR & qPCR
7.1.5.1. Market Revenue and Forecast (2021-2033)
7.1.6. Flow Cytometry
7.1.6.1. Market Revenue and Forecast (2021-2033)
7.1.7. Mass Spectrometry
7.1.7.1. Market Revenue and Forecast (2021-2033)
7.1.8. Separation Technologies
7.1.8.1. Market Revenue and Forecast (2021-2033)
7.1.9. Electron Microscopy
7.1.9.1. Market Revenue and Forecast (2021-2033)
7.1.10. NMR
7.1.10.1. Market Revenue and Forecast (2021-2033)
7.1.11. Others
7.1.11.1. Market Revenue and Forecast (2021-2033)
8.1. Life Science Tools Market, by End-User, 2024-2033
8.1.1. Biopharmaceutical Company
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Government & Academic
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Industry
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Health Care
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2033)
9.1. Life Science Tools Market, by Technology, 2024-2033
9.1.1. Genomic Technology
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Cell Biology Technology
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Proteomics Technology
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Lab Supplies & Technologies
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Other Analytical & Sample Preparation Technology
9.1.5.1. Market Revenue and Forecast (2021-2033)
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.2. Market Revenue and Forecast, by End-User (2021-2033)
10.1.3. Market Revenue and Forecast, by Technology (2021-2033)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.1.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.1.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.2. Market Revenue and Forecast, by End-User (2021-2033)
10.2.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.2.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.2.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.6.2. Market Revenue and Forecast, by End-User (2021-2033)
10.2.6.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.7.2. Market Revenue and Forecast, by End-User (2021-2033)
10.2.7.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.2. Market Revenue and Forecast, by End-User (2021-2033)
10.3.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.3.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.3.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.6.2. Market Revenue and Forecast, by End-User (2021-2033)
10.3.6.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.7.2. Market Revenue and Forecast, by End-User (2021-2033)
10.3.7.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.4.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.4.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.6.2. Market Revenue and Forecast, by End-User (2021-2033)
10.4.6.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.7.2. Market Revenue and Forecast, by End-User (2021-2033)
10.4.7.3. Market Revenue and Forecast, by Technology (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.4.2. Market Revenue and Forecast, by End-User (2021-2033)
10.5.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.5.2. Market Revenue and Forecast, by End-User (2021-2033)
10.5.5.3. Market Revenue and Forecast, by Technology (2021-2033)
11.1. Agilent Technologies
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hoffmann-La Roche Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bio-Rad Laboratories, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bruker Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Danaher Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GE Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Hitachi, Ltd.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Illumina, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Oxford Instruments plc
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Qiagen N.V.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Shimadzu Corporation
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Thermo Fisher Scientific, Inc.
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. ZEISS International
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample